Skip to Main content Skip to Navigation
New interface
Journal articles

Safety and immunogenicity after 2 doses of the BNT162b2 COVID-19 vaccine in an early-phase oncology trial centre population

Abstract : No abstract available
Document type :
Journal articles
Complete list of metadata

https://hal-amu.archives-ouvertes.fr/hal-03623103
Contributor : Jacques A NUNES Connect in order to contact the contributor
Submitted on : Tuesday, March 29, 2022 - 2:39:15 PM
Last modification on : Friday, April 1, 2022 - 3:58:11 AM

Links full text

Identifiers

Collections

Citation

Nausicaa Malissen, Laetitia Ninove, Xavier de Lamballerie, Nicolas André, Caroline Gaudy-Marqueste. Safety and immunogenicity after 2 doses of the BNT162b2 COVID-19 vaccine in an early-phase oncology trial centre population. European Journal of Cancer, 2021, 156, pp.125-126. ⟨10.1016/j.ejca.2021.07.040⟩. ⟨hal-03623103⟩

Share

Metrics

Record views

27